{"id":"https://openalex.org/W108761767","doi":null,"title":"Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans.","display_name":"Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-06-01","ids":{"openalex":"https://openalex.org/W108761767","mag":"108761767","pmid":"https://pubmed.ncbi.nlm.nih.gov/20560688"},"language":"en","primary_location":{"id":"pmid:20560688","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20560688","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W108761767"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047193469","display_name":"Jay M. Margolis","orcid":"https://orcid.org/0000-0002-9665-859X","observed_orcids":["https://orcid.org/0000-0002-9665-859X"]},"institutions":[{"id":"https://openalex.org/I68384125","display_name":"Thomson Reuters (United States)","ror":"https://ror.org/00m7gt169","country_code":"US","type":"company","lineage":["https://openalex.org/I68384125"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jay M Margolis","raw_affiliation_strings":["Thomson Reuters Healthcare, Bala Cynwyd, PA 19004, USA. jay.margolis@thomsonreuters.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomson Reuters Healthcare, Bala Cynwyd, PA 19004, USA. jay.margolis@thomsonreuters.com","institution_ids":["https://openalex.org/I68384125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016903366","display_name":"Zhun Cao","orcid":"https://orcid.org/0000-0002-7904-2523","observed_orcids":["https://orcid.org/0000-0002-7904-2523"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zhun Cao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075889741","display_name":"Eberechukwu Onukwugha","orcid":"https://orcid.org/0000-0001-8547-1810","observed_orcids":["https://orcid.org/0000-0001-8547-1810"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eberechukwu Onukwugha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091566357","display_name":"Robert J Sanchez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert J Sanchez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076045633","display_name":"Jose M. Alvir","orcid":"https://orcid.org/0000-0003-3234-9509","observed_orcids":["https://orcid.org/0000-0003-3234-9509"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jose Alvir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086818295","display_name":"Ashish V. Joshi","orcid":"https://orcid.org/0000-0002-7089-1545","observed_orcids":["https://orcid.org/0000-0002-7089-1545"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ashish V Joshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027695585","display_name":"C. Daniel Mullins","orcid":"https://orcid.org/0000-0003-4322-2490","observed_orcids":["https://orcid.org/0000-0003-4322-2490"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Daniel Mullins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.4083,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.93944987,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"16","issue":"6","first_page":"447","last_page":"456"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.30959999561309814,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.30959999561309814,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.25850000977516174,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.2020999938249588,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pregabalin","display_name":"pregabalin","score":0.9919999837875366},{"id":"https://openalex.org/keywords/prior-authorization","display_name":"prior authorization","score":0.9929999709129333},{"id":"https://openalex.org/keywords/commercial-health-plans","display_name":"commercial health plans","score":0.6710000038146973},{"id":"https://openalex.org/keywords/painful-diabetic-neuropathy","display_name":"diabetic neuropathic pain","score":0.8389999866485596},{"id":"https://openalex.org/keywords/postherpetic-neuralgia","display_name":"postherpetic neuralgia","score":1.0},{"id":"https://openalex.org/keywords/health-care-utilization","display_name":"health care utilization","score":0.8349999785423279},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.9520000219345093},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.859000027179718},{"id":"https://openalex.org/keywords/non-opioid-analgesics","display_name":"non-opioid analgesics","score":0.9610000252723694},{"id":"https://openalex.org/keywords/prescription-drug-policy","display_name":"prescription drug policy","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C2776468701","wikidata":"https://www.wikidata.org/wiki/Q412174","display_name":"Pregabalin","level":2,"score":0.9776374101638794},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9134907722473145},{"id":"https://openalex.org/C2778866549","wikidata":"https://www.wikidata.org/wiki/Q1714245","display_name":"Postherpetic neuralgia","level":3,"score":0.6675027012825012},{"id":"https://openalex.org/C2779598192","wikidata":"https://www.wikidata.org/wiki/Q17514788","display_name":"Prior authorization","level":2,"score":0.5593165755271912},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.502077579498291},{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.44806256890296936},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4444875419139862},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.442393958568573},{"id":"https://openalex.org/C2780670349","wikidata":"https://www.wikidata.org/wiki/Q12061588","display_name":"Medication therapy management","level":4,"score":0.43702298402786255},{"id":"https://openalex.org/C2778829437","wikidata":"https://www.wikidata.org/wiki/Q6806632","display_name":"Medicare Advantage","level":3,"score":0.41543048620224},{"id":"https://openalex.org/C73269764","wikidata":"https://www.wikidata.org/wiki/Q954529","display_name":"Poisson regression","level":3,"score":0.41123509407043457},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.4025808870792389},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.36345380544662476},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3222993314266205},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.2647574841976166},{"id":"https://openalex.org/C2777107010","wikidata":"https://www.wikidata.org/wiki/Q2798704","display_name":"Neuropathic pain","level":2,"score":0.16905540227890015},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.16116830706596375},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.13996997475624084},{"id":"https://openalex.org/C2779457091","wikidata":"https://www.wikidata.org/wiki/Q105186","display_name":"Pharmacist","level":3,"score":0.1385163962841034},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.1251797080039978},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.11257779598236084},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.09377038478851318},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003929","descriptor_name":"Diabetic Neuropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006297","descriptor_name":"Health Services Accessibility","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006302","descriptor_name":"Health Services Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007344","descriptor_name":"Insurance Claim Reporting","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D007356","descriptor_name":"Insurance, Pharmaceutical Services","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D019458","descriptor_name":"Insurance Coverage","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D051474","descriptor_name":"Neuralgia, Postherpetic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:20560688","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20560688","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of managed care","raw_type":"Comparative Study"},{"id":"mag:108761767","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20560688","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1969434736","https://openalex.org/W1982995093","https://openalex.org/W2003370576","https://openalex.org/W2005832128","https://openalex.org/W2010691204","https://openalex.org/W2022877567","https://openalex.org/W2041837876","https://openalex.org/W2055846831","https://openalex.org/W2061643765","https://openalex.org/W2082396702","https://openalex.org/W2087916444","https://openalex.org/W2113588072","https://openalex.org/W2118166478","https://openalex.org/W2119931634","https://openalex.org/W2121270079","https://openalex.org/W2131515329","https://openalex.org/W2138676765","https://openalex.org/W2144723507","https://openalex.org/W2149130129","https://openalex.org/W2158467616","https://openalex.org/W2160466492","https://openalex.org/W2280464480","https://openalex.org/W2282880540","https://openalex.org/W2314140878","https://openalex.org/W2398513643","https://openalex.org/W2417497575","https://openalex.org/W2426159001","https://openalex.org/W3021176487"],"related_works":["https://openalex.org/W2426159001","https://openalex.org/W2460538015","https://openalex.org/W1991760265","https://openalex.org/W2749382566","https://openalex.org/W2019091290","https://openalex.org/W2062848475","https://openalex.org/W1997160697","https://openalex.org/W2144902229","https://openalex.org/W2080798594","https://openalex.org/W2000356063"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"compare":[2],"changes":[3],"in":[4,25,37,69,139,145,161,171,202],"medication":[5,105,210,241],"use":[6,188,211],"and":[7,61,72,78,112,119,142],"costs":[8,73],"over":[9,130,166],"time":[10],"for":[11,33,50,100,222],"management":[12],"of":[13,174],"painful":[14],"diabetic":[15],"peripheral":[16],"neuropathy":[17],"(pDPN)":[18],"or":[19,93,102,205,208,212,239,242],"postherpetic":[20],"neuralgia":[21],"(PHN)":[22],"among":[23],"patients":[24,36,138,144,162],"commercial":[26],"health":[27,56,63],"plans":[28,38,57,64,141,152,173],"requiring":[29,153],"prior":[30],"authorization":[31],"(PA)":[32],"pregabalin":[34,40,59,66,164,223,228],"versus":[35],"without":[39,65],"PA":[41,60,140,154,172,220],"policies.":[42],"STUDY":[43],"DESIGN:":[44],"Retrospective":[45],"claims":[46],"data":[47],"were":[48,74,106,114,198],"obtained":[49],"2005":[51],"to":[52],"2007":[53],"from":[54],"6":[55,62],"with":[58,95,149,226],"PA.":[67],"Differences":[68],"resource":[70],"utilization":[71],"compared":[75],"between":[76],"baseline":[77],"1-year":[79],"follow-up":[80],"periods":[81],"using":[82,116,163],"a":[83,124,156],"pre-post":[84],"parallel-group":[85],"design.":[86],"METHODS:":[87],"Adults":[88],"diagnosed":[89],"as":[90],"having":[91],"pDPN":[92,207],"PHN":[94,209],"at":[96],"least":[97],"1":[98],"claim":[99],"pDPN-":[101,238],"PHN-specific":[103,240],"pain":[104],"selected.":[107],"Pharmacologic":[108],"therapy,":[109],"healthcare":[110,216,243],"utilization,":[111,229],"expenditures":[113],"analyzed":[115],"bivariate":[117],"statistics":[118],"generalized":[120],"linear":[121],"models":[122],"via":[123],"difference-in-differences":[125],"approach":[126],"comparing":[127],"cohorts":[128,135],"year":[129,165,167],"year.":[131],"RESULTS:":[132],"The":[133],"2":[134],"included":[136],"2084":[137],"1320":[143],"non-PA":[146,150],"plans.":[147],"Compared":[148],"plans,":[151],"experienced":[155],"5.0-percentage":[157],"point":[158],"lower":[159,193,227],"increase":[160],"(P":[168,182,194],"<.001).":[169],"Utilization":[170],"other":[175,206],"anticonvulsants":[176],"was":[177,189,224,232],"3.7":[178],"percentage":[179,191],"points":[180,192],"higher":[181],"=":[183,195],".03),":[184],"while":[185],"nonopioid":[186],"analgesic":[187],"5.2":[190],".01).":[196],"There":[197],"no":[199,233],"significant":[200,235],"differences":[201],"opioid,":[203],"antidepressant,":[204],"pDPNor":[213],"PHN-related":[214],"total":[215],"costs.":[217],"CONCLUSION:":[218],"A":[219],"policy":[221],"associated":[225],"but":[230],"there":[231],"statistically":[234],"effect":[236],"on":[237],"expenditures.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W108761767","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
